PD-1 and PD-L1 inhibitors in cold colorectal cancer: challenges and strategies.

Saved in:
Bibliographic Details
Title: PD-1 and PD-L1 inhibitors in cold colorectal cancer: challenges and strategies.
Authors: Lin KX; Department of Pathology, University of Western Ontario, London, ON, N6A 5A5, Canada.; Department of Physiology and Pharmacology, University of Western Ontario, London, Canada.; Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada., Istl AC; Division of Surgical Oncology, Medical College of Wisconsin, Milwaukee, WI, USA., Quan D; Department of Surgery, University of Western Ontario, London, ON, N6A 5A5, Canada., Skaro A; Department of Surgery, University of Western Ontario, London, ON, N6A 5A5, Canada., Tang E; Department of Surgery, University of Western Ontario, London, ON, N6A 5A5, Canada., Zheng X; Department of Pathology, University of Western Ontario, London, ON, N6A 5A5, Canada. xzheng26@uwo.ca.; Department of Surgery, University of Western Ontario, London, ON, N6A 5A5, Canada. xzheng26@uwo.ca.; Department of Oncology, University of Western Ontario, London, ON, N6A 5A5, Canada. xzheng26@uwo.ca.; Department of Microbiology & Immunology, University of Western Ontario, London, ON, N6A 5A5, Canada. xzheng26@uwo.ca.; Lawson Health Research Institute, London, ON, N6A 5A5, Canada. xzheng26@uwo.ca.
Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2023 Dec; Vol. 72 (12), pp. 3875-3893. Date of Electronic Publication: 2023 Oct 13.
Publication Type: Journal Article; Review
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first